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Background
In Systemic Sclerosis (SSc) the detrimental role of the
immune system is a topic of great interest. In recent
genetic association studies most genes identified to date are
immunity related genes. A contribution of T-cells as
important cytokine producing cells is shown and the skew-
ing of this population can be an important player in the
maintenance and progression of inflammation and fibrosis.
Material and methods
After inclusion 20 SSc patients were stratified as having
diffuse or limited disease according to the extent of skin
involvement. Patients were further stratified as having
early or late disease, early being less then 2 years after
the start of the first non-Raynaud symptom. After isola-
tion from 60 ml of venous blood CD4+ T-cells were
divided in CD45RO and CD45RA by MACS bead isola-
tion. Cells were stimulated with PMA and iomycin.
Cytokine levels were measured in supernatant using the
Luminex Bead Array.
Results
The IL-17 production was clearly increased in the
supernatant of CD4+CD45RO cells but even more
clearly in the CD4+CD45RA cells from early diffuse SSc
patients compared to healthy controls or limited SSc
patients. Limited SSc patients showed a clear decrease
in IL-10 and interferon-g production.
Conclusions
The CD4+CD45RA+ T-cells from early diffuse SSc patients
produce increased levels of IL-17 suggestion a more pro-
inflammatory phenotype in this T-cell subset. Together
with a normal production of IL-13 this could create a
proinflmmatory and profibrotic condition in this subset of
patients. The decreased production of IL-10 and inter-
feron-g in limited SSc patients shows a decrease of Th1
and Treg involvement in this disease subset. A prospective
study must show if these findings could contribute to the
assessing the prognosis and the treatment of SSc patients.
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